首页> 外文学位 >In Vitro Platelet Production: Promoting Megakaryocyte Terminal Differentiation, Demonstrating Platelet Functionality, and Developing an Automated Process for Platelet Harvest.
【24h】

In Vitro Platelet Production: Promoting Megakaryocyte Terminal Differentiation, Demonstrating Platelet Functionality, and Developing an Automated Process for Platelet Harvest.

机译:体外血小板生产:促进巨核细胞末端分化,展示血小板功能并开发血小板收获的自动化过程。

获取原文
获取原文并翻译 | 示例

摘要

Platelets (PLTs) produced in vitro from megakaryocytes (MKs) derived from hematopoietic stem cells (HSCs) could potentially overcome some of the limitations of donated PLTs, including contamination and recipient alloimmunization. Although significant advances have been made with respect to generating large quantities of MKs from HSCs in culture, improvements in MK maturation, including proplatelet (proPLT) formation (PPF) and PLT release, as well as in the functionality of generated PLTs, are needed for in vitro PLT production to become clinically relevant. Currently, the number of PLTs generated per MK in vitro pales in comparison to the thousands generated per MK in vivo, and in-vitro -derived PLTs often display signs of pre-activation. The aims of this work were therefore twofold: to promote in-vitro-derived MK terminal differentiation and to improve in-vitro-derived PLT functionality and recovery.;With respect to the first goal, we sought to identify factors involved in MK terminal differentiation, then develop a tunable culture surface to control these factors for improved MK PPF. We specifically explored the role of adhesion in MK polyploidization and PPF and examined changes in PPF when MKs were cultured on soft, ligand-functionalized hydrogels designed to limit cell spreading. Adhesion was found to be essential for initiation of primary MK PPF, but did not affect primary MK polyploidization.;For the second goal, we aimed to first generate functional PLTs in vitro, then develop an efficient process for harvesting PLTs soon after generation in order to maintain PLT functionality. After switching to a different serum-free medium, subjecting proPLT-forming MKs to overnight agitation, and employing a non-enzymatic cell dissociation solution during PLT harvest, we demonstrated in vitro production of functional PLTs. We subsequently adapted a commercially-available, spinning-membrane filtration device to separate in-vitro-derived PLTs and MKs without inducing PLT pre-activation. Recovered MKs exhibited PPF and shed PLTs after reseeding in culture, suggesting that the process could be used to harvest PLTs at multiple time points during culture to maximize functional PLT yield.
机译:体外由源自造血干细胞(HSC)的巨核细胞(MK)产生的血小板(PLT)可以克服捐赠的PLT的某些局限性,包括污染和受体同种免疫。尽管在培养中从造血干细胞产生大量MK方面已取得重大进展,但仍需要改善MK成熟度,包括前血小板(proPLT)形成(PPF)和PLT释放,以及产生的PLT的功能。体外生产PLT变得具有临床意义。目前,与体内每MK产生的数千个相比,体外每个MK产生的PLT的数量苍白,并且体外衍生的PLT通常显示出预激活的迹象。因此,这项工作的目的是双重的:促进体外衍生的MK终末分化,并改善体外衍生的PLT功能和恢复。关于第一个目标,我们寻求确定参与MK终末分化的因素,然后开发可调整的培养表面以控制这些因素以改善MK PPF。我们特别探讨了粘附在MK多倍体化和PPF中的作用,并检查了MK在旨在限制细胞扩散的柔软的配体功能化水凝胶上培养时,PPF的变化。发现粘附对于启动原发性MK PPF是必不可少的,但不影响原发性MK多倍体化。为第二个目标,我们的目标是首先在体外生成功能性PLT,然后开发出一种有效的方法,以便在生成PLT后立即收获维护PLT功能。切换到其他无血清培养基后,对形成proPLT的MK进行过夜搅拌,并在PLT收获过程中采用非酶细胞解离溶液,我们证明了功能性PLT的体外生产。随后,我们采用了市售的旋转膜过滤装置,以在不诱导PLT预激活的情况下分离体外衍生的PLT和MK。在播种后,恢复的MK表现出PPF并脱落PLT,这表明该过程可用于在培养期间的多个时间点收获PLT,以最大程度地发挥功能性PLT产量。

著录项

  • 作者

    Schlinker, Alaina C.;

  • 作者单位

    Northwestern University.;

  • 授予单位 Northwestern University.;
  • 学科 Chemical engineering.
  • 学位 Ph.D.
  • 年度 2014
  • 页码 224 p.
  • 总页数 224
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号